Offerings // XBiotech Inc.

XBIT offering history

Every offering-related filing in XBiotech Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 400 filings back to Dec 10, 2014.

Last executed offering

Jan 4, 2024

8-K — priced deal (shares or notes)

Last registration (announced)

May 31, 2019

S-3MEF — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Jan 4, 2024	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jun 3, 2019	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 31, 2019	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 31, 2019	S-3MEF →	REGISTERED	S-3MEF registration — capacity to sell shares, not a sale yet
May 1, 2019	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 3, 2017	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 26, 2016	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 1, 2016	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Aug 19, 2016	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Apr 16, 2015	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Apr 14, 2015	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Apr 10, 2015	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Mar 27, 2015	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Mar 27, 2015	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Mar 27, 2015	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Mar 10, 2015	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Feb 2, 2015	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet

XBIT offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full XBIT workspace →

XBIT offering FAQ

When did XBIT last execute an offering?

Per SEC filings, XBiotech Inc.'s most recent priced offering document is a 8-K filed 2024-01-04. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did XBIT last announce or register an offering?

The most recent registration is a S-3MEF filed 2019-05-31. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.